Amarin Corp Plc (AMRN)

[yellow_bluff]

When Medivation announced very positive results for its pivotal P3 in late stage prostate cancer the stock rose from about $8 to $16 (pre split). the stock shared some similarity w amrn as it had been a big dissapointment about three years prior. steadily wall street returned to mdvn and the stock eventually went to $120 pre split.

so, i think that it will take a while for amrn to fully rise on positive reduce it results.